The ADC targets CD79b on B cells, is internalized, and releases MMAE; MMAE then binds beta-tubulin (vinca site) to disrupt microtubules, causing G2/M arrest and apoptosis. Tubulin is the payload’s intracellular target, not the cell-selection target.